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Abstract
Background: The 19 kDa lipoprotein of Mycobacterium tuberculosis (MTB) is an important target
of the innate immune response. To investigate the effect of post-translation modification of this
protein on innate recognition in the context of the whole bacillus, we derived a recombinant M.
tuberculosis  H37Rv that lacked the 19 kDa gene (Δ19) and complemented this strain by
reintroduction of the 19 kDa gene into the chromosome as a single copy to produce Δ19::19. We
also reintroduced the 19 kDa gene in two modified forms that lacked motifs for acylation
(Δ19::19NA) and O-glycosylation (Δ19::19NOG).
Results: Both acylation and O-glycosylation were necessary for the protein to remain within the
cell. IL-1 Beta secretion from human monocytes was significantly reduced by deletion of the 19 kDa
gene (p < 0.02). Complementation by the wild type, but not the mutagenised gene reversed this
phenotype. The effect of deletion and complementation on IL-12p40 and TNF secretion was less
marked with no statistically significant differences between strains. Although deletion of the 19 kDa
reduced apoptosis, an effect that could also only be reversed by complementation with the wild
type gene, the results were variable between donors and did not achieve statistical significance.
Conclusion: These results confirm in the context of the whole bacillus an important role for post-
translational modification of the 19 kDa on both the cellular location and immune response to this
protein.
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Background
The vast increase in knowledge that has accompanied the
discovery of microbial pattern recognition receptors has
focussed research into the microbial ligands that initiate
these cellular responses [1,2] For example it is now known
that bacterial LPS triggers responses via Toll like receptor
(TLR) 4, and Flagellin via TLR5 [3,4]. It is also increasingly
appreciated that receptors may co-operate to recognise
specific ligands [5]. Thus triacylated lipopeptide is recog-
nised by a heterodimer of TLR2 and 1, with diacylated
lipopeptide being recognised by the TLR2/6 heterodimer
[2]. Many types of pathogens produce lipoproteins and
are thus in part recognised by TLR2 [6-8].
Mycobacterium tuberculosis has over 100 probable or
known lipoproteins, many of which are concentrated in
the cell wall [9]. Whilst a role has been assigned to some
of these proteins (e.g. Phosphate binding and transport
for the PstS1-3 group [10]), most have not been assigned
a function. They are characterised by an acylated N-termi-
nus, processing of which is mediated by the consecutive
activity of prolipoprotein diacylglyceryl transferase (Lgt)
and lipoprotein signal peptidase (LspA) [11]. Deletion of
LspA reduces the virulence of M. tuberculosis. In addition
many of the lipoproteins have been found to be targets of
both the innate and acquired immune response. A prom-
inent target of the innate response is the 19 kDa lipopro-
tein encoded by Rv3763. This molecule has been
intensively researched because of its pleiotropic effects on
the innate immune response that include induction of
cytokine genes, bacterial killing, induction of apoptosis,
and the downregulation of Interferon-γ (IFN-γ) induced
MHC Class II expression [12-20]. More recently it has also
been suggested that the 19 kDa protein acts an adhesin
[21].
Many of the above studies of the 19 kDa were performed
with purified or recombinant protein that may not fully
reflect the role of the molecule in the context of natural
infection. In particular expression in E. coli is unlikely to
reproduce native patterns of post-translational modiufica-
tion. We have previously reported the effect of deletion
and overexpression of the 19 kDa on the innate immune
response [22]. We found that the deletion mutant (Δ19)
was moderately impaired in its ability to multiply in
human monocyte-derived macrophages (MDM). Surface
expression of MHC class II molecules was reduced in
phagocytes infected with MTB; this effect was not seen in
cells infected with Δ19. Δ19 induced lower IL-1β secretion
from monocytes and MDM. Overexpression of the 19 kDa
increased IL-1β, IL-12p40 and TNF-α secretion irrespec-
tive of phagocyte maturity. These findings confirmed the
19 kDa protein to be an important mediator of the innate
immune response in the context of the whole bacillus.
In addition to being acylated, the 19 kDa protein is glyco-
sylated [23,24]. Earlier work in our laboratories estab-
lished that poly threonine motifs towards the N-terminal
of the molecule form a major glycosylation site [23,24].
The aim of this study was therefore to evaluate the innate
immune response to Δ19 mutants that had been comple-
mented with a single copy of mutagenised 19 kDa mole-
cules lacking the motifs for acylation and O-glycosylation
respectively.
Methods
Generation of recombinant strains of M. tuberculosis
The 19 kDa gene was deleted from M. tuberculosis (MTB)
H37Rv to produce the Δ19 strain as previously described
[22]. Complementation of the Δ19 strain by the native
and modified (non-acylated NA, and non-O-glycosylated
NOG) 19 kDa genes led to the strains Δ19::19, Δ19::19NA
and  Δ19::19NOG. For complementation, the native
sequence (including the entire intergenic region and part
of upstream Rv3762 ORF) was amplified by PCR from
H37Rv DNA. The site-directed mutagenised genes were
amplified from previous episomal constructs [24,25]
engineered to come under the control of the endogenous
19 kDa promoter. Complementation was performed
using the integrating vector pKINTA, based on the L5
phage integration system [26], which reintroduces a single
copy of the 19 kDa gene into the chromsome under the
control of its own promoter at the attB site [27]. PCR was
used to confirm deletion and insertion as previously
described [22] and sequencing of the pKINTA insert con-
firmed nucleotide differences that would result in substi-
tution of the N-terminal cysteine residue of the mature
wild-type protein with alanine in Δ19::19NA; and substi-
tution of two threonine clusters (5 amino acids in total)
by valine residues in Δ19::19NOG. For Western blotting
supernatants and sonicated preparations of wild-type M.
tuberculosis  H37Rv and the deleted and complemented
strains were fractionated by SDS-PAGE and expression of
the 19 kDa antigen compared by Western blot analysis
using a polyclonal anti-19 kDa serum.
Isolation and culture of monocytes
Buffy coats from healthy donors were obtained from the
National Blood Transfusion Service (Colindale, London,
UK). Following dilution in RPMI (1/3 vol/vol), peripheral
blood mononuclear cells (PBMC) were separated by cen-
trifugation over Ficoll-Paque Plus (Pharmacia, Uppsala,
Sweden). Cells were washed in RPMI and counted. Cells
were suspended at 1.2 × 107/ml in RPMI/10% FCS
medium and aliquots of 25 mls were added to 150 cm2 tis-
sue culture flasks. Flasks were placed flat in a 5% CO2
incubator and monocytes allowed to adhere for 2 h at
37°C. Non-adherent cells were removed by washing 3
times with 10 mls of pre-warmed RPMI. Finally, 10 mls of
ice-cold PBS was added and the flasks were incubated atBMC Microbiology 2009, 9:93 http://www.biomedcentral.com/1471-2180/9/93
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4°C for 20 mins. Using a scraper, monocytes were gently
dislodged from the bottom of the flasks and pooled in a
50 ml Falcon tube to count. Cells were plated in RPMI
containing 10% serum at 106/well in a 24-well tissue cul-
ture plate, and cultured overnight before infection.
Infection of cells
Bacilli used to infect cells were grown in Middlebrook
7H9 broth supplemented with ADC to mid-log phase
(OD 0.4–0.8) then frozen in aliquots in 15% glycerol. The
CFU content of aliquots was determined by serial dilution
and plating on Middlebrook 7H11 agar supplemented
with OADC. Monocytes were infected at a multiplicity of
infection of 1:1 without removing non-phagocytosed bac-
teria. Culture duration was 72 hrs., at which time superna-
tants were aspirated, 0.22 μm filtered, and stored at -80°C
pending analysis by ELISA.
ELISA
Cytokine ELISA was performed using the DuoSet ELISA
Development Systems (R&D Systems, Minneapolis, MN)
following the manufacturer's recommendations. The sen-
sitivity of the assays was 15 pg/ml for IL-12p40, 10 pg/ml
for IL-1β and 50 pg/ml for TNF-α. Histone associated
DNA fragments, released into tissue culture supernatant
and interpreted as evidence of apoptotic cell death, were
assayed by the cell death detection ELISA (Roche Applied
Science, Lewes, Sussex, UK) according to the manufac-
turer's instructions.
Sequence analysis
Homologues of the M. tuberculosis 19 kDa gene LpqH
were identified by Blast searches of sequenced genomes
[28]. Alignment of protein sequences was performed
using Clustal W and results are displayed as a sequence
pile-up and as a neighbour-joining tree. Strains and
genome accession numbers: M. tuberculosis H37Rv,
AL123456.2;  M. smegmatis MC2155, CP000480.1; M.
ulcerans  Agy99, CP000325.1; M. marinum M,
CP000854.1; M. leprae TN, AL450380.1; M. avium subsp.
paratuberculosis  K-10, AE016958.1; M. abscessus,
CU458896.1; Nocardia farcinica IFM 10152, AP006618.1;
Rhodococcus sp. RHA1, CP000431.1.
Statistical methods
Paired and unpaired parametric variables were compared
by student's t-test. Paired and unpaired non-parametric
variables were compared by Wilcoxon signed rank or
Mann Whitney U test respectively. Significance was
inferred for p values ≤ 0.05.
Results
Bioinformatic analysis of 19 kDa genes in various 
mycobacteria
The 19 kDa or LpqH lipoprotein of M. tuberculosis belongs
to a family of conserved proteins that is ubiquitous
through the mycobacteria and is also found in the closely
related Nocardia farcinica and Rhodococcus but not in other
high GC gram positive bacteria such as Streptomyces and
Corynebacteria. In addition to the lpqH gene, M. tuberculosis
possesses a paralogous gene encoding the lipoprotein
LppE. Other mycobacteria have varying numbers of 19
kDa gene homologs with the fast-growing M. abscessus
possessing 6 paralogous genes. Figure 1 shows an align-
ment of twenty seven 19 kDa family proteins identified
from genome sequencing projects. Displayed as a neigh-
bour-joining tree, it is apparent that the 19 kDa proteins
fall into three general sub-families: LpqH-like proteins,
LppE-like proteins and a third subfamily that we term Lp3
(Figure 2A). All except one protein (the M. marinum
MMAR5315 protein is truncated) contain a predicted
secretion signal sequence with the N-terminus of mature
proteins containing a cysteine residue. Twenty-one out of
twenty-six predicted full-length 19 kDa proteins including
the M. tuberculosis LpqH and LppE proteins, comply with
the lipobox consensus acylation motif [29]. This is con-
sistent with the approximately 75% predictive value of the
lipobox based on experimental evidence of known
prokaryote lipoproteins. Cysteine residues at positions 67
and 158 (relative to the M. tuberculosis sequence) and phe-
nylalanine at position 152 are conserved throughout the
family. Strongly and weakly conserved groups of amino
acids are also highlighted in Figure 2B. O-glycosylation
does not occur at a particular motif of amino acids but
occurs at specific residues, generally threonine and serine.
The M. tuberculosis LpqH 19 kDa protein is glycosylated at
a triplet and a pair of threonines at positions 14–16 (rela-
tive to the start of the mature protein) and 19–20 [24].
Threonine pairs are also found in several other 19 kDa
family proteins including, for example, the predicted pro-
tein from N. farcinica which has two pairs of threonine
residues at positions 11–12 and 15–16. In addition, many
of the 19 kDa homologs have N-terminal regions of the
mature protein that are rich in serine residues which may
be indicative of glycosylation. Taken together, it seems
likely that N-terminal glycosylation and acylation are gen-
eral features of the 19 kDa protein family. The broad dis-
tribution of this family across mycobacteria and closely
related genera suggests that these lipoproteins fulfil some
conserved physiological function which at present
remains largely unknown. To screen for a possible role for
the 19 kDa lipoprotein in mycobacterial physiology, we
therefore generated a deletion mutant lacking the 19 kDa
molecule and complemented this mutant with the wild
type and site-mutagenised copies of the 19 kDa molecule.
Generation and characterization of recombinant M. 
tuberculosis strains
PCR analysis showed Rv3763 to be absent from Δ19 and
that this sequence had been successfully reintroduced into
strains  Δ19::19,,  Δ19::19NA, and Δ19::19NOG (Figure
3A). Western Blotting of cellular pellet indicated that theBMC Microbiology 2009, 9:93 http://www.biomedcentral.com/1471-2180/9/93
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19 kDa was not produced in Δ19 (Figure 3B, lane 2).
Expression of native protein of the same MW was restored
close to normal levels by reintroduction of the 19 kDa
gene in strain Δ19::19 (Figure 3B, lane 3). 19 kDa protein
was only detected in the supernatant of cultures of the
non-acylated (NA) and non-O-glycosylated comple-
mented strains and was of slightly lower MW than the
native 19 kDa. In Middlebrook 7H9 broth the growth rate
of the Δ19, Δ19::19, Δ19::19NA, and Δ19::19NOG strains
was identical (Figure 4).
Cytokine secretion
Human monocytes were infected with equal numbers of
bacilli (moi 1:1) and co-cultured for 72 hours. During this
period, the median secretion of IL-1β was significantly
reduced by deletion of the 19 kDa gene (Figure 5A, p =
0.02). Introduction of the native 19 kDa gene as Δ19::19
restored secretion to wild type levels but the response to
Δ19::19NA and Δ19::19NOG remained significantly less
when compared to Δ19::19 (p = 0.031 in both cases).
There was no difference between H37Rv, Δ19 and Δ19::19
in their ability to elicit IL-12p40 or TNF from monocytes
(Figure 5B and 5C). Although the response to both the
Δ19::19NA and Δ19::19NOG strains tended to be lower,
these differences were also not significantly different from
H37Rv.
Sequence alignment of 27 open reading frames belonging to the 19 kDa family Figure 1
Sequence alignment of 27 open reading frames belonging to the 19 kDa family. Highly conserved cysteine, and phe-
nylalanine residues are highlighted. "*" indicates fully conserved positions; ":" indicates strong conservation; "." Indicates weaker 
conservation. The 0-glycosylated threonine residues in the M. tuberculosis LpqH are boxed. Fully compliant Lipobox acylation 
motifs are underlined.
M.marinum-MMAR5315               -----------------------------------------------------------------------------------MTGSVVCTTAAGNVNIA
M.ulcerans-MUL4389               -------MKRGPTVAVAGAAILVAGLSGCSS-NKSTTSGGESSSTG-------------STSASTGGGQASGTKVLIDGQDQHVTGSVVCTTAAGNVNIA
M.tuberculosis-19kD LpqH Rv3763  -------MKRGLTVAVAGAAILVAGLSGCSS-NKSTTGSGETTTAA-------------GTTASPG--AASGPKVVIDGKDQNVTGSVVCTTAAGNVNIA
M.avium paratuberculosis-MAP0261 -------MKRQLTIAVAGAAILAAGVSGCSSGNKS--APSSSASSS-------------STSASASSGGAAGTKVIIDGKDQNVSGSVVCTNAGGTVNIA
M.intracellulare                 -------MKRQLTVAVAGAAILAAGISGCSGGNKSGTSASSSASSS-------------STSASASSGGAAGTKVIIDGKDQNVSGSVVCTNAGGTVNIA
M.avium paratuberculosis-MAP0584 -------MKRGIVVGLAGVALVIGASAGCSS----------NKSNT-------------GASGSSGAPAAAAPQLIVDGQTQNVSGQVTCTTNGDKTTIG
M.abscessus-MAB2379              ------MQRTGSVVVIGAGAIIALGLAGCSGDGNESAPSSAEKTT--------------VSAEGGAAAMNSSAKVVVDGKEKKVEGAIACSTAAGQVNIG
M.abscessus-MAB0885c             -------MKRGLVVAIGGAAIVAAGLVGCSGDKDK---SETKGTT--------------VSNSAGAVATNSSAKVTIDGKEQKIEGAVVCQSSNGNVNIV
M.smegmatis-MSMEG6316            -------MKRGFLVAVGSAALVVAGLSGCSSDDKSAEASEASPTANATVDSTASPGTSVAAGDATATTGTGTARVVIDGAEHPIEGSVVCATVAGNVSVT
M.leprae-ML1966                  --------MRHKLLAAIYAVTIMAGAAGCSGGTQAPTPSVSKTTNS----------SPTTVASSIPDAAAGETKVTIGGQPQKVSGPVVCSTTNGKFSIA
M.abscessus-MAB3261c             -------MRYGSAVVMGGAVLAGACFVGCSSGEGVHRDSSQTSQRV-------------SNSASVTPAAG-PRVVVNGAVRTVENR-VECVTAGEMTFVN
M.abscessus-MAB0884c             -------MKRVWAAVVGGAMLAATQSS-CAASTQITKITDSATSPA-------------KPEQSSTPEGG-TATMTVGALAVVAGAPVRCDAYEQRTFIS
M.smegmatis-MSMEG6315            -----MELVVNRLVAAAGCAALLTGVAGCSSQDSNDAGQSPATE---------------SDGPAATPVEADQGKVVLGGNELGPVTAIGCETSDGLTTIT
M.marinum-MMAR5244               MEGNPVKRVIAAAIGTIGCAS---ALVGCSSGGHSASPASSVS----------------------TGGGGTQVQVGGTNLPGLDPASVTCVKQGGKIDIG
M.ulcerans-MUL4320               -----MKRVIAAAIGTIGCAS---ALVGCSSGGHSASPASSVS----------------------TGGGGTQVQVGGTNLPGLDPASVTCVKQGGKIDIG
M.avium paratuberculosis-MAP0326 -----MKRLLAAATGTLGCAAAAVTLVGCSSGGHSAAPASSTAPS-------------------ASTGTNAQVKVGGADLPGVNPASVTCVRTGGKIDIG
M.smegmatis-MSMEG3803            --------MNRVIAGTMGLLAAGTILVGCSDDKPQATPSPAAAD--------------------VKTGGNTQVKVDGKDLPGLDLNSVTCVKEGGRINVG
M.abscessus-MAB4074c             ----------------MGLLAAGAVVVGCSNDKP-----AGAAQ--------------------VSSGSNAEVKVDGKDLAGLDLKSVTCVKQGGNINVA
Nocardia_farcinica               -MNTTLRSTALRATAIASAAALALLVSACGDDTETAAPTTSATTSA---------------AAPAAPAGKSAAAVDGKALDAG--FETTCAKQGDTLALA
Rhodococcus sp. RHA1 ro0327      MNKIVRTQKRVYTAGIVAAAAVALLVSGCSDTGDSNSGGGSSEQS----------------PAAANPAGASSAAVDGKALEAD--FDATCAKQGDTLALA
M.marinum-MMAR2769               -------MQIRLVTVTGLALSLVAAVSGCG-SAMTVPRQAAHVTID---------------------------------GSTHTARPAACSQEQSYRTID
M.ulcerans-MUL2978               -------MQIRLVTVTGLAMSVVAAVSGCG-SAMTVPRQAAHVTID---------------------------------GSTHTARPAACSQEQSYRTID
M.tuberculosis-LppE Rv1881c      -------VCNRLVTVTGVAMVVAAGLSACG-QAQTVPRKAARLTID---------------------------------GVTHTTRPATCSQEHSYRTID
M.avium paratuberculosis-MAP1604c-------MQKRLPTVVLVLTAVVAGIAGCS-AAQTVPRKAARLTID---------------------------------GATHTTRPPSCRQDQMYRTIN
M.marinum-MMAR4690               --------MRNLIKLAFVCVLASAGLTGCGSSSGSQLASTASMTVN---------------------------------GADVHPRVVRCTQIEWYRTIQ
M.ulcerans-MUL0309               --------MRNPIKLAFVCLLASAGLTGCGSSSGSQLASTASMTVN---------------------------------GADVQPRVVRCTQIEWYRTIQ
M.avium paratuberculosis-MAP0778 ---------VRNRFVAAGAALTVALLGACTSRPPAQLSSTASVTVD---------------------------------GKDRNFHIVTCRQLEWRRMID
                                                             *                                                            *        : 
M.marinum-MMAR5315               IGGAATG------IAAVLTDANPPEVKSVGLGNVNG--VTLGYTSGTGQ--GNASATKDGSSYKISGTATGVDMANPMSP--VNKPFEINVTCP-----
M.ulcerans-MUL4389               IGGAATG------IAAVLTDANPPEVKSVGLGNVNG--VTLGYTSGTGQ--GNASATKDGSSYKISGTATGVDMANPMSP--VNKPFEINVTCP-----
M.tuberculosis-19kD LpqH Rv3763  IGGAATG------IAAVLTDGNPPEVKSVGLGNVNG--VTLGYTSGTGQ--GNASATKDGSHYKITGTATGVDMANPMSP--VNKSFEIEVTCS-----
M.avium paratuberculosis-MAP0261 IGGAATG------IAAVLSDGNPPQVKSVGLGNVNG--VTLGYTSGTGQ--GNASAEKNGNSYKITGTATGVDMANPLQP--VNKPFEIDVTCNS----
M.intracellulare                 IGGAATG------IAAVLSDGNPPQVKSVGLGNVNG--VTLGYTSGTGQ--GNATASKDGNSYKISGTATGVDMANPMQP--VNKPFEINVTCNS----
M.avium paratuberculosis-MAP0584 IGDPTAG------LGAVVSNGNPPLVHSVGLGTVNG--VALGFSDAAPNQGGNAGAAVNGKTWAIKGTATGVDMSNPQQPQQVTKSFELDATCP-----
M.abscessus-MAB2379              MGAGMQA------IAVVLSDGDSPKVTSVGLGNIDG--VTLGFADGAPG--GKATATKDGKKYTVTGTATGVDTANPMQ--PIEKPFEIEVTCP-----
M.abscessus-MAB0885c             IGSGAQG------FGAVVTEGDSPTVKSAGLGSLNG--QSLAFSEGTPG--ASAKATKDGKKYHIEGTAIAVDMANPTQ--PSNKPFEIEVTCP-----
M.smegmatis-MSMEG6316            VGQGTSA------VTATLSEGDQPAVSAVALGNIDG--VSLGYTPGVPG--GSAEATKDGNKYTIKGSATGADMANPMAG-AVTKPFELEITCP-----
M.leprae-ML1966                  IGDMITG------VIVGLEP-DASVVHNAGLGTIDG--VVIAFTEGVPS--ENANATKNGNTYQITGTASGVDNTGQQIH----KSFEIEVTCR-----
M.abscessus-MAB3261c             IGSDSDG------IAARLTAGESPSLESLTLGVIDG--QPVIYSPSN--GGAKPEVTKSGRSYKIAGPATAGL-STPAT-------FELEFTCPAGR--
M.abscessus-MAB0884c             VAKDPDA------RGLTLTG-EPPAIETVNLGEVNG--LKFMYYELLKKDGESATLTKDGKHYTVKGTVRGSD-SQGADG--MIKPFRVDVTCP-----
M.smegmatis-MSMEG6315            IESDVR-------TTVKVTEGEAPNVESVNIGDVWS--DGPSVVYMSGLSEVPVVATRDGDTYTVAGIGMGADPADPSVP--ADTPFDIAVTCP-----
M.marinum-MMAR5244               SGSAG----GQQALAVVMTDEATPRVESLALVVDGN---ALSVTDNMGAKVGSAKVAVEGKTYTITGQAQGA-DMKNPMAGMITKDFSIKVTCG-----
M.ulcerans-MUL4320               SGSAG----GQQALAVVMTDEATPRVESLALVVDGN---AVSVTDNMGAKVGSAKVAVEGKTYTITGQAQGA-DMKNPMAGMITKDFSIKVTCG-----
M.avium paratuberculosis-MAP0326 SGSTGG---AQQALAVVLTDEATPKVESLALVVDGN---ALAVSNNMGAKVGSADVAVDGKTYTITGQAQGA-DMKNPMAGMITKDFSIKVSCG-----
M.smegmatis-MSMEG3803            SAAIG----GQQGLGVVMTDEASPKVESLGLVYDGS---ALAVSENMGVKVGSADVKVDGKTYTITGEASGA-DVKNPMAGMITKPFTIKVSCG-----
M.abscessus-MAB4074c             SAAIN----GQQGLGVVMTDEATPKVTSLGLVYDGA---ALAVSEGMGAKVGSADVKVDGKTYTITGEASGA-DVKNPMAGMITKPFTIKVSCG-----
Nocardia farcinica               LTDNNNATYGQLTVSATVTG-DTVQAVGIAGSKGGSAGMPYALGYGNGQPGGSAKLAKDGNTFTITGEGVGAPDMTNPLAGPSTATFEITFACTDIVGA
Rhodococcus sp. RHA1 ro03270     LADTANSTYGDLAVSATITGADTVQAVGIAGSKGGSNGLPYALGFGQGMPGGSATVVKDGDTYTISGEGVGAPDMSNPTA-PSSSKFDITFACSTVVGG
M.marinum-MMAR2769               IGDRDGH-----VQAVVLISGERVIPQWVKIRNIDG-----FNGSYWQGGVGEAQVGLSHGTYTITGSAYGIGSDNPNKV--VTTDFKIVAEC------
M.ulcerans-MUL2978               IGDRDGH-----VQAVVLISGERVIPQWVKIRNVDG-----FNGSYWQGGVGEAQVDFSHGTYTITGRAYGIGSDNPNKV--VTTDFKIVAEC------
M.tuberculosis-LppE Rv1881c      IRNHDST-----VQAVVLLSGDRVIPQWVKIRNVDG-----FNGSFWHGGVGNARADRARNTYTVAGSAYGISSKKPNTV--VSTDFNILAEC------
M.avium paratuberculosis-MAP1604cIPDHDGG-----VEAVVLLSGYRVMPQWVKIRNVDG-----FTGSYWQGGVGDAHVDLTNDAYTITGSAYGINSANPNKV--VTTDFKIVAEC------
M.marinum-MMAR4690               IGDQASG-----VRVLIDQGARPMIAKSVRITNLGG-----FTGMYAQGDGGDAGLHFSDGRFTITGNADGYNTDKPAEP--TTAAFRISVNC------
M.ulcerans-MUL0309               IGDQASG-----VRILIDQGARPMIAKSVRITNLGG-----FTGMYAQGDGGDAGLHFSDGRFTITRNADGYNTDKPAEP--TTAAFRISVNC------
M.avium paratuberculosis-MAP0778 IGADFSG-----AKVAVDENAQPPVVESVHIQNLSG-----FSGMYSRGGSGSADMSMTGDKFTISGTADGYKTDKPSEP--ATATFKIVVTC------
                                                                                               : :     .               * :   *       BMC Microbiology 2009, 9:93 http://www.biomedcentral.com/1471-2180/9/93
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Induction of apoptosis
Culture supernatants from 6 donors were also assayed for
the presence of Histone associated DNA fragments, a
marker of apoptosis. Results for each subject were normal-
ised to unstimulated cells to generate an enrichment fac-
tor. The Δ19 and Δ19::19NA and Δ19::19NOG were
associated with lower levels than H37Rv or the Δ19::19
strain. However responses varied considerably between
A. Neighbour-joining tree of 19 kDa homologs Figure 2
A. Neighbour-joining tree of 19 kDa homologs. Family members are found in both slow-growing and fast-growing myco-
bacteria and in the closely related genera, Nocardia and Rhodococcus. The predicted 19 kDa proteins fall into three sub-families: 
LpqH, LppE and Lp3. B. Nucleotide sequence of the N-terminal coding sequence of the 19 kDa gene indicating the sequences 
that were modified in the Δ19 strains complemented by the non-acylated or non-O-glycosylated 19 kDa molecule. The disrup-
tion to sequence encoding the N-Acyl diglyceride motif is indicated by underlined text and the disruption of the 2 threonine 
clusters shown in bold. The protein sequence of the wild type and each variant is also shown. Amino acid numbering is based 
upon the mature protein after cleavage of the signal peptide.
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Characterization of mutant M. tuberculosis strains Figure 3
Characterization of mutant M. tuberculosis strains. A. PCR analysis showed Rv3763 to be absent from Δ19 and that this 
sequence had been successfully reintroduced into strains Δ19::19,, Δ19::19NA, and Δ19::19NOG. B. Western Blotting of cellu-
lar pellet indicating that the 19 kDa is not produced in Δ19 (lane 2). Expression of native protein of the same MW is restored 
close to normal levels by reintroduction of the 19 kDa gene in strain Δ19::19. C. Analysis of pellet and culture supernatant of 
complemented mutant strains. 19 kDa protein was only detected in the supernatant of cultures of the non-acylated (NA) and 
non-O-glycosylated complemented strains and was of slightly lower MW than the native 19 kDa.
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Growth of strains in Middlebrook 7H9 broth Figure 4
Growth of strains in Middlebrook 7H9 broth. Duplicate log phase cultures of each strain were normalised to an O.D. of 
0.05 and cultured with shaking with the O.D. repeated at intervals. No difference in the maximum rate of growth of the strains 
was observed.
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Secretion of IL-1β, IL-12p40 and TNF in response to strains of M. tuberculosis Figure 5
Secretion of IL-1β, IL-12p40 and TNF in response to strains of M. tuberculosis. Monocytes from 7 donors were 
infected with strains and co-cultured for 72 hours. The median secretion of IL-1β was significantly reduced by deletion of the 
19 kDa gene (p = 0.02). Introduction of the native 19 kDa gene as Δ19::19 restored secretion to wild type levels but the 
response to Δ19::19NA and Δ19::19NOG remained significantly less when compared to Δ19::19 (p = 0.031 in both cases). No 
differences existed between strains in their ability to induce the secretion of IL-12p40 or TNF.BMC Microbiology 2009, 9:93 http://www.biomedcentral.com/1471-2180/9/93
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donors and none of these trends attained statistical signif-
icance (Figure 6).
Discussion
We have investigated deletion of the 19 kDa lipoprotein
(Rv3763) from M. tuberculosis and chromosomal comple-
mentation of the deletion mutant by the wild type gene
and site directed mutagenised variants lacking motifs for
acylation and O-glycosylation. We have determined that
both acylation and O-glycosylation are necessary for the
protein to remain within the cell. Consistent with our pre-
vious findings, the 19 kDa is an important stimulus for
the production of pro-inflammatory IL-1β, an effect that
is dependent on acylation and O-glycosylation. The effect
of deletion and complementation on IL-12p40 and TNF
secretion was less marked with no statistically significant
differences between strains. Although deletion of the 19
kDa reduced apoptosis, an effect that could also only be
reversed by complementation with the wild type gene, the
results were variable between donors and did not attain
statistical significance.
An interesting finding was that 19 kDa protein was only
detected in the supernatant of cultures of the non-acylated
(NA) and non-O-glycosylated complemented strains,
whereas the Δ19::19 strain expressed the molecule in both
pellet and supernatant. This suggests that in order to be
retained within the cell wall both acylation and glycosyla-
tion are necessary for anchoring within the cell wall.
Whether this relates to a specific physicochemical interac-
tion or merely reflects the recognised hydrophobicity of
the mycobacterial cell membrane remains to be deter-
mined. Sartain and Belisle have recently shown that o-gly-
cosylation affects the positioning in the cell wall but not
the enzymatic activity of the superoxide dismuase sodC
[30].
In a previous study overexpression of the 19 kDa in M.
smegmatis reduced its capacity to induce the secretion of
IL-12p40 and TNF[18]. This effect was dependent on
acylation and glycosylation, as tranformation of, M. smeg-
matis with NA and NOG variants of the 19 kDa did not
reduce the secretion of these cytokines. By contrast over-
expression of the native 19 kDa molecule in Δ19 strain of
virulent M. tuberculosis had precisely the opposite effect,
with the production of IL-12p40 and TNF increased irre-
spective of phagocyte maturity [22]. In this study we
reintroduced the 19 kDa gene as a single copy into the
chromosome of H37Rv under the control of its own pro-
moter. We precisely reproduced our previous findings
with respect to the effect of deletion of the 19 kDa on the
cytokine response of monocytes. We have shown that the
19 kDa mediated induction of IL-1β is dependent on
acylation and glycosylation. Taken together these and
other studies suggest a consistent effect of acylation and
O-glycosylation on the cytokine response to the 19 kDa,
but that the genetic background and level of expression
are also important. Further evidence in favour of this
hypothesis is our recent finding that a naturally occuring
M. tuberculosis strain that lacks the 19 kDa gene does not
have the same in vitro phenotype as the engineered knock
out on the Rv background (data not shown). This poten-
tially important finding requires further investigation as
much of our knowledge about gene function in M. tuber-
culosis is inferred from studies of isogenic mutants on the
H37Rv background.
Considerable evidence now points to the protective role
of macrophage apoptosis in tuberculosis. Apoptosis may
prevent the release of intracellular components and the
spread of mycobacterial infection by sequestering the
pathogens within apoptotic bodies [14,31,32]. In addi-
tion, uptake of apoptotic debris by competent phagocytes
allows efficient cross-presentation of M. tuberculosis anti-
gens [33]. Thus, the avoidance of apoptosis may be con-
sidered a virulence mechanism and a recent study has in
fact reported a inverse relationship between the intracellu-
lar growth rate and the ability of strains to induce apopto-
sis [34]. Two previous studies have implicated the 19 kDa
as pro-apoptotic [14,17] and our results, although varia-
ble between donors tend to support this conclusion.
However the dependence or otherwise on post-translation
modification requires additional work as the findings of
Induction of apoptosis by strains of M. tuberculosis Figure 6
Induction of apoptosis by strains of M. tuberculosis. 
Monocytes from 6 donors were infected with strains and co-
cultured for 72 hours. Apoptosis was determined by ELISA 
for nucleosomal fractions in culture supernatants. Results for 
each subject were normalised to unstimulated cells to gener-
ate an enrichment factor. The mean + SD of this enrichment 
factor is shown. Although the Δ19 strain tended to induce 
less apoptosis than H37Rv and Δ19::19 none of the differ-
ences were statistically significant.
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Lopez et al. suggested that this effect was acylation inde-
pendent, whereas the trend in our study suggest acylation
is necessary (Figure 6).
Conclusion
In conclusion we have presented further evidence of the
role of the 19 kDa as a key modulator of the human innate
immune response. There is considerable evidence that the
protein downregulates IFN-γ induced macrophage activa-
tion, an effect that will tend to favour bacillary survival
during the development of an acquired immune response.
On the other hand the molecule will tend to give away the
presence of bacilli to the innate system early in infection,
perhaps teleologically explaining why it is not upregu-
lated early after infection [22]. In addition, this work pro-
vides further evidence of the utility of defined mutants to
delineate key determinants of the innate immune
response in the context of whole bacilli.
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